Insider · CIK 0001555851

Rawcliffe Adrian

Reports to the SEC for 3 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001555851

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-05	WVEWave Life Sciences, Inc.A Award	Director	AAward	+10.7K sh	—	—	10,700
2026-10-05	WVEWave Life Sciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+64K sh	—	—	64,000
2026-08-12	WVEWave Life Sciences, Inc.S Sale	Director	SSale	−12.7K sh	$5.29	−$67.2K	0
2025-12-08	WVEWave Life Sciences, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+42K sh	$5.97	+$251K	54,700
2025-12-08	WVEWave Life Sciences, Inc.S Sale	Director	SSale	−42K sh	$15.00	−$630K	12,700
2025-12-08	WVEWave Life Sciences, Inc. · Share Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−42K sh	—	—	0
2025-11-13	WVEWave Life Sciences, Inc.S Sale	Director	SSale	−16.1K sh	$6.79	−$109K	12,700
2025-08-11	WVEWave Life Sciences, Inc.A Award	Director	AAward	+12.7K sh	—	—	28,815
2025-08-11	WVEWave Life Sciences, Inc. · Share Option (right to buy)A Award	Director	AAward	+76.2K sh	—	—	76,200
2025-02-20	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Director, Chief Executive Officer	AAward	+5.14M sh	—	—	5,143,248
2025-02-20	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Director, Chief Executive Officer	AAward	+3.43M sh	—	—	3,428,832
2025-01-17	ADAPAdaptimmune Therapeutics PLCS Sale	Director, Chief Executive Officer	SSale	−30.6K sh	$0.58	−$17.8K	44,327
2025-01-15	ADAPAdaptimmune Therapeutics PLCS Sale	Director, Chief Executive Officer	SSale	−29.1K sh	$0.57	−$16.7K	41,582
2025-01-13	ADAPAdaptimmune Therapeutics PLCS Sale	Director, Chief Executive Officer	SSale	−12.5K sh	$0.59	−$7,371.678	17,801
2025-01-13	ADAPAdaptimmune Therapeutics PLCS Sale	Director, Chief Executive Officer	SSale	−17.9K sh	$0.59	−$10.5K	25,711
2024-08-12	WVEWave Life Sciences, Inc.A Award	Director	AAward	+16.1K sh	—	—	16,115
2024-08-12	WVEWave Life Sciences, Inc. · Share Option (right to buy)A Award	Director	AAward	+32.2K sh	—	—	32,230
2024-01-17	ADAPAdaptimmune Therapeutics PLCS Sale	Director, Chief Executive Officer	SSale	−30.1K sh	$0.67	−$20.2K	44,848
2024-01-16	ADAPAdaptimmune Therapeutics PLCS Sale	Director, Chief Executive Officer	SSale	−9,304 sh	$0.79	−$7,350.16	14,104
2024-01-15	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Director, Chief Executive Officer	AAward	+7.63M sh	—	—	7,633,296
2024-01-15	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Director, Chief Executive Officer	AAward	+1.7M sh	—	—	1,696,272
2024-01-12	ADAPAdaptimmune Therapeutics PLCS Sale	Director, Chief Executive Officer	SSale	−17.3K sh	$0.85	−$14.7K	26,388
2024-01-11	ADAPAdaptimmune Therapeutics PLCS Sale	Director, Chief Executive Officer	SSale	−11.9K sh	$0.84	−$9,994.382	18,395
2023-09-01	ADAPAdaptimmune Therapeutics PLCS Sale	Director, Chief Executive Officer	SSale	−2,403 sh	$0.78	−$1,874.34	3,449
2023-08-07	WVEWave Life Sciences, Inc. · Share Option (right to buy)A Award	Director	AAward	+45K sh	—	—	45,000
2023-06-27	ADAPAdaptimmune Therapeutics PLCS Sale	Director, Chief Executive Officer	SSale	−2,333 sh	$0.92	−$2,146.36	3,519
2023-01-17	ADAPAdaptimmune Therapeutics PLCS Sale	Director, Chief Executive Officer	SSale	−10.1K sh	$1.86	−$18.7K	13,351
2023-01-17	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Director, Chief Executive Officer	AAward	+4.69M sh	—	—	4,690,224
2023-01-17	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Director, Chief Executive Officer	AAward	+1.8M sh	—	—	1,798,272
2023-01-12	ADAPAdaptimmune Therapeutics PLCS Sale	Director, Chief Executive Officer	SSale	−18.8K sh	$1.71	−$32K	24,882
2023-01-11	ADAPAdaptimmune Therapeutics PLCS Sale	Director, Chief Executive Officer	SSale	−13K sh	$1.75	−$22.8K	17,298
2023-01-04	ADAPAdaptimmune Therapeutics PLCS Sale	Director, Chief Executive Officer	SSale	−5,073 sh	$1.69	−$8,593.662	6,631
2022-09-01	ADAPAdaptimmune Therapeutics PLCS Sale	Director, Chief Executive Officer	SSale	−2,536 sh	$1.97	−$4,993.13	3,316
2022-08-15	WVEWave Life Sciences, Inc. · Share Option (right to buy)A Award	Director	AAward	+21K sh	—	—	21,000
2022-06-27	ADAPAdaptimmune Therapeutics PLCS Sale	Director, Chief Executive Officer	SSale	−2,562 sh	$1.63	−$4,176.06	3,290
2022-01-18	ADAPAdaptimmune Therapeutics PLCS Sale	Director, Chief Executive Officer	SSale	−11.1K sh	$3.19	−$35.4K	12,312
2022-01-12	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Director, Chief Executive Officer	AAward	+4.69M sh	—	—	4,690,224
2022-01-12	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Director, Chief Executive Officer	AAward	+1.05M sh	—	—	1,047,480
2022-01-12	ADAPAdaptimmune Therapeutics PLCS Sale	Director, Chief Executive Officer	SSale	−3,046 sh	$3.54	−$10.8K	3,356
2022-01-11	ADAPAdaptimmune Therapeutics PLCS Sale	Director, Chief Executive Officer	SSale	−14.4K sh	$3.56	−$51.1K	15,978
2022-01-04	ADAPAdaptimmune Therapeutics PLCS Sale	Director, Chief Executive Officer	SSale	−5,532 sh	$4.06	−$22.5K	6,172
2021-09-01	ADAPAdaptimmune Therapeutics PLCS Sale	Director, Chief Executive Officer	SSale	−2,782 sh	$5.20	−$14.5K	3,070
2021-08-16	WVEWave Life Sciences, Inc. · Share Option (right to buy)A Award	Director	AAward	+42K sh	—	—	42,000
2021-06-28	ADAPAdaptimmune Therapeutics PLCS Sale	Director, Chief Executive Officer	SSale	−2,794 sh	$4.37	−$12.2K	3,058
2021-01-19	ADAPAdaptimmune Therapeutics PLCS Sale	Director, Chief Executive Officer	SSale	−9,879 sh	$5.67	−$56K	13,529
2021-01-12	ADAPAdaptimmune Therapeutics PLCS Sale	Director, Chief Executive Officer	SSale	−2,707 sh	$6.15	−$16.7K	3,695
2021-01-11	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Director, Chief Executive Officer	AAward	+3.26M sh	—	—	3,260,400
2021-01-11	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Director, Chief Executive Officer	AAward	+728K sh	—	—	728,160
2021-01-04	ADAPAdaptimmune Therapeutics PLCS Sale	Director, Chief Executive Officer	SSale	−4,967 sh	$5.33	−$26.5K	6,737
2020-09-01	ADAPAdaptimmune Therapeutics PLCS Sale	Director, Chief Executive Officer	SSale	−2,776 sh	$8.51	−$23.6K	3,076

Recent filings

Accepted (ET)
Oct 74
Rawcliffe Adrian0001193125-26-417233
SEC(opens sec.gov)
Aug 134
Rawcliffe Adrian0001193125-26-349962
SEC(opens sec.gov)
Dec 104
Rawcliffe Adrian0001193125-25-314742
SEC(opens sec.gov)
Nov 144
Rawcliffe Adrian0001193125-25-283619
SEC(opens sec.gov)
Aug 134
Rawcliffe Adrian0000950170-25-108286
SEC(opens sec.gov)
Feb 204
Rawcliffe Adrian0001104659-25-015739
SEC(opens sec.gov)
Jan 174
Rawcliffe Adrian0001104659-25-004605
SEC(opens sec.gov)
Jan 154
Rawcliffe Adrian0001104659-25-003775
SEC(opens sec.gov)
Aug 144
Rawcliffe Adrian0000950170-24-097290
SEC(opens sec.gov)
Jan 174
Rawcliffe Adrian0001104659-24-004564
SEC(opens sec.gov)
Jan 174
Rawcliffe Adrian0001104659-24-004520
SEC(opens sec.gov)

Companies

Address

C/O WAVE LIFE SCIENCES, INC., 733 CONCORD AVE.

CAMBRIDGE, MA, 02138